Siegfried Schmidt

1.5k total citations · 1 hit paper
43 papers, 910 citations indexed

About

Siegfried Schmidt is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Pharmacology. According to data from OpenAlex, Siegfried Schmidt has authored 43 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 17 papers in Anesthesiology and Pain Medicine and 11 papers in Pharmacology. Recurrent topics in Siegfried Schmidt's work include Pain Management and Opioid Use (17 papers), Opioid Use Disorder Treatment (15 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Siegfried Schmidt is often cited by papers focused on Pain Management and Opioid Use (17 papers), Opioid Use Disorder Treatment (15 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Siegfried Schmidt collaborates with scholars based in United States, Italy and Spain. Siegfried Schmidt's co-authors include Lawrence J. Lesko, Roger B. Fillingim, Robert W. Hurley, Ku-Lang Chang, André P. Mauderli, Yu‐Jung Jenny Wei, Kristin Weitzel, Almut G. Winterstein, Christopher A. Harle and John G. Gums and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Diabetes Care.

In The Last Decade

Siegfried Schmidt

39 papers receiving 871 citations

Hit Papers

Advanced Liver Fibrosis Is Common in Patients With Type 2... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siegfried Schmidt United States 15 241 172 151 142 136 43 910
Andrew Joyce United States 12 385 1.6× 274 1.6× 96 0.6× 169 1.2× 26 0.2× 19 851
Gudrun Høiseth Norway 18 215 0.9× 86 0.5× 87 0.6× 30 0.2× 109 0.8× 66 953
Timothy J. Wiegand United States 18 79 0.3× 223 1.3× 74 0.5× 93 0.7× 134 1.0× 63 991
Célia Lloret‐Linares France 19 91 0.4× 93 0.5× 95 0.6× 89 0.6× 113 0.8× 51 1.1k
A.R.W. Forrest United Kingdom 17 80 0.3× 124 0.7× 70 0.5× 36 0.3× 162 1.2× 43 1.1k
Eric P.A. van Dongen Netherlands 20 107 0.4× 42 0.2× 48 0.3× 239 1.7× 107 0.8× 55 1.1k
Berend Mets United States 20 85 0.4× 74 0.4× 24 0.2× 228 1.6× 34 0.3× 82 1.2k
Jeffrey Schein United States 24 251 1.0× 118 0.7× 151 1.0× 80 0.6× 79 0.6× 58 1.9k
Mark E. Sutter United States 17 87 0.4× 157 0.9× 22 0.1× 64 0.5× 43 0.3× 47 1.1k
Espen Jimenez‐Solem Denmark 21 130 0.5× 492 2.9× 163 1.1× 21 0.1× 33 0.2× 100 1.5k

Countries citing papers authored by Siegfried Schmidt

Since Specialization
Citations

This map shows the geographic impact of Siegfried Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siegfried Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siegfried Schmidt more than expected).

Fields of papers citing papers by Siegfried Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siegfried Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siegfried Schmidt. The network helps show where Siegfried Schmidt may publish in the future.

Co-authorship network of co-authors of Siegfried Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Siegfried Schmidt. A scholar is included among the top collaborators of Siegfried Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siegfried Schmidt. Siegfried Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hong, Jung Hwa, Debbie L. Wilson, Khoa A. Nguyen, et al.. (2025). Protocol for a Single-Arm Pilot Clinical Trial: Developing and Evaluating a Machine Learning Opioid Prediction & Risk-Stratification E-Platform (DEMONSTRATE). Journal of Clinical Medicine. 14(23). 8522–8522.
2.
Wei, Yu‐Jung Jenny, Almut G. Winterstein, Siegfried Schmidt, et al.. (2025). Outcomes of Discontinuing Long-Term Opioid Therapy among Older Cancer Survivors in Long-Term Care Settings. Journal of the American Medical Directors Association. 26(4). 105522–105522.
3.
Wei, Yu‐Jung Jenny, Siegfried Schmidt, Roger B. Fillingim, et al.. (2025). Unrelieved pain and risk of opioid use disorder or overdose in older adults prescribed opioids. Pain. 166(9). e252–e260.
4.
Wei, Yu‐Jung Jenny, Almut G. Winterstein, Siegfried Schmidt, et al.. (2025). Association of initiating CYP2D6-metabolized opioids with risks of adverse outcomes in older adults receiving antidepressants: A retrospective cohort study. PLoS Medicine. 22(6). e1004620–e1004620.
5.
Wei, Yu‐Jung Jenny, Almut G. Winterstein, Siegfried Schmidt, et al.. (2024). Short- and long-term safety of discontinuing chronic opioid therapy among older adults with Alzheimer’s disease and related dementia. Age and Ageing. 53(3). 1 indexed citations
6.
Nguyen, Khoa A., Debbie L. Wilson, Bradley R. Hall, et al.. (2024). Design and development of a machine-learning-driven opioid overdose risk prediction tool integrated in electronic health records in primary care settings. SHILAP Revista de lepidopterología. 10(1). 24–24. 2 indexed citations
7.
Wang, Yanning, Debbie L. Wilson, Jeffrey Budd, et al.. (2023). Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review. Journal of Clinical Medicine. 12(5). 1788–1788. 5 indexed citations
8.
Wei, Yu‐Jung Jenny, Cheng Chen, Ting‐Yuan David Cheng, et al.. (2022). Association of injury after prescription opioid initiation with risk for opioid-related adverse events among older Medicare beneficiaries in the United States: A nested case-control study. PLoS Medicine. 19(9). e1004101–e1004101. 2 indexed citations
9.
Wei, Yu‐Jung Jenny, Cheng Chen, Roger B. Fillingim, et al.. (2021). Uncontrolled Pain and Risk for Depression and Behavioral Symptoms in Residents With Dementia. Journal of the American Medical Directors Association. 22(10). 2079–2086.e5. 24 indexed citations
10.
Wei, Yu‐Jung Jenny, Siegfried Schmidt, Cheng Chen, et al.. (2021). Quality of opioid prescribing in older adults with or without Alzheimer disease and related dementia. Alzheimer s Research & Therapy. 13(1). 78–78. 18 indexed citations
11.
Cicali, Emily J., Ku-Lang Chang, Siegfried Schmidt, et al.. (2021). Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease. The Pharmacogenomics Journal. 21(6). 657–663. 8 indexed citations
12.
Lomonaco, Romina, Eddison Godinez Leiva, Fernando Bril, et al.. (2020). Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening. Diabetes Care. 44(2). 399–406. 231 indexed citations breakdown →
13.
Smith, D. Max, Kristin Weitzel, Amanda R. Elsey, et al.. (2019). CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial. Genetics in Medicine. 21(8). 1842–1850. 105 indexed citations
14.
Wei, Yu‐Jung Jenny, et al.. (2019). Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016. Drug and Alcohol Dependence. 204. 107600–107600. 12 indexed citations
15.
Delcher, Chris, et al.. (2017). Trends in Florida's Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use. Journal of Opioid Management. 13(5). 283–289. 11 indexed citations
16.
Harle, Christopher A., Neil Marlow, Siegfried Schmidt, et al.. (2016). The effect of EHR-integrated patient-reported outcomes on satisfaction with chronic pain care.. PubMed. 22(12). e403–e408. 11 indexed citations
17.
Harle, Christopher A., et al.. (2016). The Effect of EHR-Integrated Patient Reported Outcomes on Satisfaction with Chronic Pain Care. IUScholarWorks (Indiana University). 9 indexed citations
18.
Chang, Ku-Lang, Kristin Weitzel, & Siegfried Schmidt. (2015). Pharmacogenetics: Using Genetic Information to Guide Drug Therapy.. PubMed. 92(7). 588–94. 19 indexed citations
19.
Frye, Reginald F., Rhonda M. Cooper‐DeHoff, Jonathan J. Shuster, et al.. (2010). Atenolol Exposure and Risk for Development of Adverse Metabolic Effects: A Pilot Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(9). 872–878. 8 indexed citations
20.
Schmidt, Siegfried, et al.. (2003). Evaluation of a Quality Improvement Intervention for Diabetes Management. Journal for Healthcare Quality. 25(3). 26–32. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026